Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis

Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis

It is important to develop minimally invasive biomarker platforms to help in the identification and monitoring of patients with Alzheimer’s disease (AD). Assisting in the understanding of biochemical mechanisms as well as identifying potential novel biomarkers and therapeutic targets would be an add...

Full description

Bibliographic Details
Main Authors: Jay S. Hanas, James R. S. Hocker, Christian A. Vannarath, Megan R. Lerner, Scott G. Blair, Stan A. Lightfoot, Rushie J. Hanas, James R. Couch, Linda A. Hershey
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Brain Sciences
Subjects:
Alzheimer’s disease (AD)
biochemical phenotype analysis
serum profiling
mass spectrometry
VWF/ADAMTS13 axis
traumatic brain injury (TBI)
Online Access:https://www.mdpi.com/2076-3425/11/5/583

Similar Items

Similar Items